Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 8/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13486222 | 0.82 | HPGD (0.71) | HPGDALDH1A1HSD17B10CYP1A2CYP3A4 | |
| SCHEMBL6281941 | 0.76 | HPGD (0.69) | HPGDALDH1A1HSD17B10CYP1A2CYP3A4 | |
| SCHEMBL5625518 | 0.76 | HPGD (0.67) | HPGDALDH1A1HSD17B10CYP1A2CYP3A4 | |
| SCHEMBL108225 | 0.76 | ALDH1A1 (0.90) | HPGDALDH1A1HSD17B10CYP1A2CYP3A4 | |
| SCHEMBL30009093 | 0.74 | GAA (0.38) | HPGDHSD17B10GAANPC1 | |
| SCHEMBL5970063 | 0.73 | HPGD (1.00) | HPGDALDH1A1HSD17B10CYP1A2CYP3A4 | |
| SCHEMBL30009231 | 0.73 | TAS1R3 (0.43) | HSD17B10GAANPC1 | |
| SCHEMBL30009435 | 0.73 | PROKR1 (0.49) | HSD17B10GAAGFERNPC1 | |
| SCHEMBL9309209 | 0.72 | HPGD (0.65) | HPGDALDH1A1HSD17B10CYP1A2CYP3A4 | |
| SCHEMBL30009010 | 0.72 | LMNA (0.45) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | HK INNO.N CORPORATION (KR) | 2022-12-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | MAP3K20, MAP3K15, MAP3K1 | HPGD 2910/4885ALDH1A1 4182/4885HSD17B10 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.